Literature DB >> 16808771

Incidence of and factors associated with achieving target lipid levels in patients with peripheral arterial disease.

Meggan R Banta1, Fangchao Ma, Dawn M Bravata, Robert S Kirsner, Daniel G Federman.   

Abstract

BACKGROUND: Patients with peripheral arterial disease (PAD) have increased mortality compared with patients without PAD. Coronary artery disease (CAD) accounts for almost 75% of deaths in PAD patients. Studies suggest that PAD is underdiagnosed and atherosclerotic risk factors undertreated when compared with CAD.
OBJECTIVE: To determine whether cholesterol guidelines are being met in patients with PAD and to determine whether any independent factors increase the likelihood of reaching goal low-density lipoprotein (LDL).
DESIGN: A retrospective chart review of subjects diagnosed with PAD in 2001 at 2 Veterans Affairs Medical Centers. MEASUREMENTS: Univariate analysis compares baseline characteristics between those reaching goal and those who do not. Multivariate logistic regression analysis identified predictors of meeting LDL goal among PAD patients.
RESULTS: Of 315 patients, 62% reached goal LDL. Those more likely to reach goal were older, had hypertension, and a history of CAD and stroke. Positive predictors of LDL goal were age and CAD, while smoking was a negative predictor.
CONCLUSION: The majority of veterans with PAD received lipid-lowering medication and achieve goal LDL, but they are more likely to do so if they are older than 70 and have a history of CAD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808771      PMCID: PMC1924706          DOI: 10.1111/j.1525-1497.2006.00456.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  17 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Secondary prevention of coronary artery disease in patients undergoing elective surgery for peripheral arterial disease.

Authors:  C M Nass; J K Allen; R M Jermyn; L A Fleisher
Journal:  Vasc Med       Date:  2001       Impact factor: 3.239

3.  Suboptimal intensity of risk factor modification in PAD.

Authors:  Roberta K Oka; Eva Umoh; Andrzej Szuba; John C Giacomini; John P Cooke
Journal:  Vasc Med       Date:  2005-05       Impact factor: 3.239

4.  The ratio of ankle and arm arterial pressure as an independent predictor of mortality.

Authors:  M McKenna; S Wolfson; L Kuller
Journal:  Atherosclerosis       Date:  1991-04       Impact factor: 5.162

5.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

6.  Atherosclerotic risk factor control in patients with peripheral arterial disease.

Authors:  Thomas F Rehring; Brian G Sandhoff; Ryan S Stolcpart; John A Merenich; H Whitton Hollis
Journal:  J Vasc Surg       Date:  2005-05       Impact factor: 4.268

7.  Peripheral arterial disease detection, awareness, and treatment in primary care.

Authors:  A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

Review 8.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

9.  Management of hyperlipidemia in patients with vascular disease.

Authors:  Maria C Cote; Robert Ligeti; Bruce S Cutler; Peter R Nelson
Journal:  J Vasc Nurs       Date:  2003-06

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more
  5 in total

1.  Low-Density Lipoprotein Cholesterol Levels and Statin Treatment by HIV Status Among Multicenter AIDS Cohort Study Men.

Authors:  Anne K Monroe; Wei Fu; Michelle N Zikusoka; Lisa P Jacobson; Mallory D Witt; Frank J Palella; Lawrence A Kingsley; Wendy S Post; Todd T Brown
Journal:  AIDS Res Hum Retroviruses       Date:  2015-03-09       Impact factor: 2.205

2.  Process of care and outcomes in patients with peripheral arterial disease.

Authors:  Tracie C Collins; Rebecca J Beyth; David B Nelson; Nancy J Petersen; Maria E Suarez-Almazor; Ruth L Bush; Alan T Hirsch; Carol M Ashton
Journal:  J Gen Intern Med       Date:  2007-04-24       Impact factor: 5.128

3.  First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients.

Authors:  Ioanna Xanthopoulou; Periklis Davlouros; Simos Siahos; Angelos Perperis; Evangelia Zaharioglou; Dimitrios Alexopoulos
Journal:  Lipids Health Dis       Date:  2013-11-09       Impact factor: 3.876

4.  Determinants of coronary artery disease risk factor management across three world regions.

Authors:  Min Zhao; Ian Graham; Marie Therese Cooney; Diederick E Grobbee; Ilonca Vaartjes; Kerstin Klipstein-Grobusch
Journal:  Heart Asia       Date:  2019-03-08

5.  Effect of surgical treatment on lipid peroxidation parameters and antioxidant status in the serum of patients with peripheral arterial disease.

Authors:  Krzysztof Wojciech Strzyżewski; Maria Pioruńska-Stolzmann; Wacław Majewski; Magdalena Kasprzak; Wojciech Strzyżewski
Journal:  Dis Markers       Date:  2013-11-03       Impact factor: 3.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.